Rachel M. Leskowitz, Ph.D.
Affiliations: | 2014 | Cell and Molecular Biology | University of Pennsylvania, Philadelphia, PA, United States |
Area:
Cell Biology, Immunology, Virology BiologyGoogle:
"Rachel Leskowitz"Parents
Sign in to add mentorHildegund Ertl | grad student | 2014 | Penn | |
(EBNA1-specific T cell responses during persistent rhesus LCV infection and the development of a novel therapeutic prototype vaccine for EBV-associated diseases.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Bagley SJ, Logun M, Fraietta JA, et al. (2024) Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results. Nature Medicine |
Garfall AL, Cohen AD, Susanibar-Adaniya SP, et al. (2022) Anti-BCMA/CD19 CAR T cells with early immunomodulatory maintenance for multiple myeloma responding to initial or later-line therapy. Blood Cancer Discovery |
Gladney W, Hexner E, Salas-McKee J, et al. (2020) Pre-clinical development of multiplex-CRISPR-edited cell and gene therapy products Cytotherapy. 22: S35 |
Gohil M, Dai A, Mackey S, et al. (2019) Myeloid derived suppressor cells (MDSCS) reduce the manufacturing feasibilty of gene modified T cells. Cytotherapy. 21: S19 |
Ohayon Y, Corl C, Leskowitz R, et al. (2018) Robust automated cell counter and viability measurement for engineered T cell product release Cytotherapy. 20: S69 |
Davis M, Fesnak A, Leskowitz R, et al. (2017) Predictors of manufacturing (MFG) success for chimeric antigen receptor (CAR) T cells in Non-Hodgkin Lymphoma (NHL) Cytotherapy. 19: S118-S119 |
Levine B, Leskowitz R, Davis M. (2015) Personalized gene therapy locks out HIV, paving the way to control virus without antiretroviral drugs. Expert Opinion On Biological Therapy. 15: 831-43 |
Leskowitz R, Fogg MH, Zhou XY, et al. (2014) Adenovirus-based vaccines against rhesus lymphocryptovirus EBNA-1 induce expansion of specific CD8+ and CD4+ T cells in persistently infected rhesus macaques. Journal of Virology. 88: 4721-35 |
Silveira EL, Fogg MH, Leskowitz RM, et al. (2013) Therapeutic vaccination against the rhesus lymphocryptovirus EBNA-1 homologue, rhEBNA-1, elicits T cell responses to novel epitopes in rhesus macaques. Journal of Virology. 87: 13904-10 |
Leskowitz RM, Zhou XY, Villinger F, et al. (2013) CD4+ and CD8+ T-cell responses to latent antigen EBNA-1 and lytic antigen BZLF-1 during persistent lymphocryptovirus infection of rhesus macaques. Journal of Virology. 87: 8351-62 |